ATAI Life Sciences NV ATAI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:56 PM EDT
1.75quote price arrow down-0.11 (-5.65%)
Volume
1,568,741
52 week range
1.02 - 2.85
Loading...
  • Open1.87
  • Day High1.89
  • Day Low1.75
  • Prev Close1.86
  • 52 Week High2.85
  • 52 Week High Date04/04/24
  • 52 Week Low1.02
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap291.376M
  • Shares Out166.03M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change24.58

KEY STATS

  • Open1.87
  • Day High1.89
  • Day Low1.75
  • Prev Close1.86
  • 52 Week High2.85
  • 52 Week High Date04/04/24
  • 52 Week Low1.02
  • 52 Week Low Date12/01/23
  • Market Cap291.376M
  • Shares Out166.03M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change24.58

RATIOS/PROFITABILITY

  • EPS (TTM)-0.24
  • P/E (TTM)-7.31
  • Fwd P/E (NTM)-2.51
  • EBITDA (TTM)-116.005M
  • ROE (TTM)-14.72%
  • Revenue (TTM)277,000.01
  • Gross Margin (TTM)-
  • Net Margin (TTM)-11,790.25%
  • Debt To Equity (MRQ)8.83%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ATAI Life Sciences NV

 

Profile

MORE
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002...
Florian Brand
Chief Executive Officer, Co-Founder
Anne Johnson
Chief Financial Officer
Address
Wallstrasse 16
Berlin
10179
Germany

Top Peers

SYMBOLLASTCHG%CHG
ERAS
Erasca Inc
1.98+0.13+7.03%
AVXL
Anavex Life Sciences Corp
4.55+0.05+1.22%
OPT
Opthea Ltd
3.40-0.18-5.03%
VSTM
Verastem Inc
11.85-0.28-2.31%
AVIR
Atea Pharmaceuticals Inc
3.69-0.01-0.14%